Abbott Laboratories

Consolidated Cash Flow Statement

US$ in millions
12 months ended: Dec 31, 2023
Net earnings 5,723
Depreciation 1,277
Amortization of intangible assets 1,966
Share-based compensation 644
Investing and financing losses, net 126
Loss on extinguishment of debt —
Trade receivables (356)
Inventories (232)
Prepaid expenses and other assets (542)
Trade accounts payable and other liabilities (760)
Income taxes (585)
(Increase) decrease
Adjustments in operating
to reconcile earnings capital
to net cash from operating (2,475)
activities 1,538
Net cash from operating activities 7,261
Acquisitions of property and equipment (2,202)
Acquisitions of businesses and technologies, net of cash acquired (877)
Proceeds from business dispositions 40
Purchases of investment securities (159)
Proceeds from sales of investment securities 43
Other 22
Net cash used in investing activities (3,133)
Proceeds
Proceeds from issuance (repayments)
from issuance of short-term
of long-term debt debt,maturities
and debt with net and other 21
over 3 months 2
Repayments of long-term debt and debt with maturities over 3 months (2,498)
Purchases of common shares (1,227)
Proceeds from stock options exercised 167
Dividends paid (3,556)
Other —
Net cash used in financing activities (7,091)
Effect of exchange rate changes on cash and cash equivalents (23)
Net increase (decrease) in cash and cash equivalents (2,986)
Cash and cash equivalents, beginning of year 9,882
Cash and cash equivalents, end of year 6,896
Source: https://www.stock-analysis-on.net/NYSE/Company/Abbott-Laboratories/Financial-Statement/Statement-of-Cash-Flows
 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
6,933 7,071 4,495 3,687
1,254 1,491 1,195 1,078
2,013 2,047 2,132 1,936
685 640 546 519
215 55 425 184
— — — 63
(68) (383) (924) (275)
(1,413) (456) (493) (593)
(75) (312) (627) (138)
420 1,288 1,766 220
(383) (908) (614) (545)
(1,519) (771) (892) (1,331)
2,648 3,462 3,406 2,449
9,581 10,533 7,901 6,136
(1,777) (1,885) (2,177) (1,638)
— (187) (42) (170)
48 134 58 48
(185) (173) (83) (103)
152 77 10 21
22 26 19 27
(1,740) (2,008) (2,215) (1,815)
47 (204) 2 —
7 4 1,281 1,842
(753) (48) (1,333) (3,441)
(3,795) (2,299) (403) (718)
167 255 245 298
(3,309) (3,202) (2,560) (2,270)
— — (11) —
(7,636) (5,494) (2,779) (4,289)
(122) (70) 71 (16)
83 2,961 2,978 16
9,799 6,838 3,860 3,844
9,882 9,799 6,838 3,860
/Statement-of-Cash-Flows